Since tranilast responsibilities through TGF-β pathway, it seems also tamoxifen influences this pathway [20], we hypothesize that combination of tamoxifen and tranilast may an appropriate therapeutic option for breast cancer management. This evidence concerns the gene TGFB1 and breast cancer.